We have been instrumental in the discovery of four drugs now on the market
We leverage our accomplishments in drug discovery with our determination to remain at the cutting edge of research to deliver innovation for industry and academia. As your partner, we provide you with robust and cutting edge scientific expertise, honed in global pharma, along with the steadfast support required in a fast-paced and challenging industry.
WHYUS
We offer a unique blend of broad scientific expertise, global pharma heritage, and unprecedented success in bringing drug discovery projects from conception to the clinic. With a passionate, interdisciplinary and accomplished team, and capabilities ranging from target validation to clinical candidate nomination, we bring great science to your project.
LatestNews
A new year and a new publication
EIB provides €15 million to fund coronavirus research at IRBM
IRBM Drug Discovery Chemistry, April 18-21, 2022
Experimental and in silico approaches to target selection and tractability for drug discovery, March 21, 2022
Heidi Kingdon Jones, Global Vice President of Sales & Marketing is attending the ‘Experimental and in silico approaches to target…
NewsHighlights
The Power of NMR in Drug Discovery
Structural biology (SB) provides a critical drug discovery and development tool for accurately identifying and understanding the structure of a target. Alessandro Piai, PhD, Principal Research Scientist at IRBM, describes the company’s expertise in nuclear magnetic resonance (NMR) and how it can be leveraged to accelerate the identification of molecules for progression to the clinic.